Skip to main content
S. 2198 118th Congress Senate

Prescription Drug Supply Chain Pricing Transparency Act

Official title: A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.

Introduced: June 22, 2023 Introduced by: Michael F. Bennet Democratic · Colorado See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 22, 2023
Read twice and referred to the Committee on Finance.
Jun 22, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 22, 2023

Read twice and referred to the Committee on Finance.

 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2198: Prescription Drug Supply Chain Pricing Transparency Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2198/
MLA
"S. 2198: Prescription Drug Supply Chain Pricing Transparency Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2198/.
Bluebook (legal)
S. 2198, 118th Cong. (2026), https://openamerica.io/bill/118-S-2198/.
Markdown link
[S. 2198: Prescription Drug Supply Chain Pricing Transparency Act](https://openamerica.io/bill/118-S-2198/)
Report a problem